The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
Marks
I M
IM
Institute of Psychiatry, London, England.
De Albuquerque
A
A
Cottraux
J
J
Gentil
V
V
Greist
J
J
Hand
I
I
Liberman
R L
RL
Relvas
J S
JS
Tobeña
A
A
Tyrer
P
P
D000379:Agoraphobia / Q000188:drug therapy / Q000523:psychology; D000525:Alprazolam / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005239:Fear; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D010200:Panic; D010352:Patient Dropouts; D010919:Placebos; D019966:Substance-Related Disorders / Q000209:etiology
D010919:Placebos; D000525:Alprazolam